Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Dechra Pharmaceuticals plc

18 Dec 2023 13:44

RNS Number : 1776X
Barclays PLC
18 December 2023

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DECHRA PHARMACEUTICALS PLC

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

15 Dec 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

1p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

7,564,249

6.64%

2,640,037

2.32%

(2)

Cash-settled derivatives:

and/or controlled:

927,330

0.81%

7,493,071

6.58%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

8,491,579

7.46%

10,133,108

8.90%

(b)

Rights to subscribe for new securities (including directors and other executive

options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

1p ordinary

Purchase

41,952

38.4072 GBP

1p ordinary

Purchase

22,288

38.4400 GBP

1p ordinary

Purchase

19,069

38.4000 GBP

1p ordinary

Purchase

14,161

38.4001 GBP

1p ordinary

Purchase

8,009

38.3980 GBP

1p ordinary

Purchase

4,873

38.4147 GBP

1p ordinary

Purchase

3,827

38.4370 GBP

1p ordinary

Purchase

2,981

38.4275 GBP

1p ordinary

Purchase

1,691

38.4250 GBP

1p ordinary

Purchase

1,409

38.4274 GBP

1p ordinary

Purchase

875

38.4305 GBP

1p ordinary

Purchase

768

38.4318 GBP

1p ordinary

Purchase

756

38.4104 GBP

1p ordinary

Purchase

503

38.4200 GBP

1p ordinary

Purchase

465

38.4262 GBP

1p ordinary

Purchase

367

38.4185 GBP

1p ordinary

Purchase

103

38.4100 GBP

1p ordinary

Purchase

56

38.4017 GBP

1p ordinary

Purchase

51

38.4047 GBP

1p ordinary

Sale

300,000

38.4800 GBP

1p ordinary

Sale

29,280

38.4000 GBP

1p ordinary

Sale

19,550

38.4600 GBP

1p ordinary

Sale

19,260

38.4041 GBP

1p ordinary

Sale

1,924

38.4135 GBP

1p ordinary

Sale

546

38.4085 GBP

1p ordinary

Sale

349

38.4069 GBP

1p ordinary

Sale

168

38.4400 GBP

1p ordinary

Sale

152

38.4200 GBP

1p ordinary

Sale

103

38.4100 GBP

1p ordinary

Sale

103

38.4011 GBP

1p ordinary

Sale

22

38.3916 GBP

1p ordinary

Sale

8

38.3975 GBP

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

1p ordinary

SWAP

Decreasing Long

1,685

38.4114 GBP

1p ordinary

SWAP

Decreasing Long

5,578

38.4241 GBP

1p ordinary

SWAP

Decreasing Long

17,729

38.4000 GBP

1p ordinary

SWAP

Decreasing Short

1

38.4061 GBP

1p ordinary

SWAP

Decreasing Short

7

38.3961 GBP

1p ordinary

SWAP

Decreasing Short

22

38.3916 GBP

1p ordinary

SWAP

Decreasing Short

103

38.4100 GBP

1p ordinary

SWAP

Decreasing Short

185

38.4000 GBP

1p ordinary

SWAP

Decreasing Short

1,277

38.4036 GBP

1p ordinary

SWAP

Decreasing Short

1,733

38.4200 GBP

1p ordinary

SWAP

Decreasing Short

2,341

38.4080 GBP

1p ordinary

SWAP

Decreasing Short

17,479

38.4025 GBP

1p ordinary

SWAP

Decreasing Short

19,550

38.4600 GBP

1p ordinary

SWAP

Increasing Long

1,686

38.4038 GBP

1p ordinary

SWAP

Increasing Short

1

38.4038 GBP

1p ordinary

SWAP

Increasing Short

1

38.4238 GBP

1p ordinary

SWAP

Increasing Short

51

38.4048 GBP

1p ordinary

SWAP

Increasing Short

91

38.4000 GBP

1p ordinary

SWAP

Increasing Short

145

38.4200 GBP

1p ordinary

CFD

Increasing Short

363

38.4032 GBP

1p ordinary

CFD

Increasing Short

1,045

38.4000 GBP

1p ordinary

SWAP

Increasing Short

1,053

38.4104 GBP

1p ordinary

SWAP

Increasing Short

3,851

38.4269 GBP

1p ordinary

SWAP

Increasing Short

3,915

38.3978 GBP

1p ordinary

SWAP

Increasing Short

8,709

38.4007 GBP

1p ordinary

SWAP

Increasing Short

8,746

38.4279 GBP

1p ordinary

SWAP

Increasing Short

8,978

38.4324 GBP

1p ordinary

SWAP

Increasing Short

21,929

38.4400 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

18 Dec 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETEADAPFLADFFA
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.